Inflammatory responses after intracoronary mononuclear BM cell therapy in swine

Bone Marrow Transplantation

Volumn 44, Issue 7, 2009, Pages 427-431

  Xu, S ^a   Xu, X ^a   Guo, Y ^a   Gao, W ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE DURATION; GRAFT RECIPIENT; HEART VENTRICLE FUNCTION; INFLAMMATION; INTRACORONARY INFUSION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SWINE; TREATMENT RESPONSE;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL SEPARATION; DISEASE MODELS, ANIMAL; HEART; INFLAMMATION MEDIATORS; INFUSIONS, PARENTERAL; INTERLEUKIN-10; INTERLEUKIN-8; MYOCARDIAL INFARCTION; REGENERATION; SWINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 70350297760     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.52     Document Type: Article

References (21)

1. Assmus B, Schächinger V, Teupe C, Britten M, Lehmann R, Döbert N et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002; 106: 3009-3017.
2. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004; 364: 141-148.
3. Ince H, Petzsch M, Kleine HD, Eckard H, Rehders T, Burska D et al. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: Final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 2005; 112 (Suppl): I73-I80.
4. Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science 1994; 264: 98-101.
5. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
6. Slack JM. Stem cells in epithelial tissues. Science 2000; 287 1431-1433.
7. Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 2005; 39: 363-376.
8. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428: 668-673.
9. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-668.
10. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C et al Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005; 96: 127-137.
11. Martins TB, Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Roberts WL et al. Risk factor analysis of plasma cytokines in patients with coronary artery disease by a multiplexed fluorescent immunoassay. Am J Clin Pathol 2006; 125: 906-913.
12. Akasaka Y, Morimoto N, Ishikawa Y, Fujita K, Ito K, Kimura-Matsumoto M et al. Myocardial apoptosis associated with the expression of proinflammatory cytokines during the course of myocardial infarction. Mod Pathol 2006; 19: 588-598.
13. Shan K, Kurrelmeyer K, Seta Y, Wang F, Dibbs Z, Deswal A et al. The role of cytokines in disease progression in heart failure. Curr Opin Cardiol 1997; 12: 218-223.
14. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995; 270: 9558-9563.
15. Chalikias GK, Tziakas DN, Kaski JC, Kekes A, Hatzinikolaou EI, Stakos DA et al. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome. Int J Cardiol 2007; 117 333-339.
16. Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes IK, Kortsaris AX et al. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease. J Am Coll Cardiol 2006; 48: 2471-2481.
17. Welt FG, Losordo DW. Cell therapy for acute myocardial infarction: Curb your enthusiasm? Circulation 2006; 113: 1272-1274.
18. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31-47.
19. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K, ASTAMI investigators. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J 2005; 39: 150-158.
20. Lunde K, Solheim S, Aakhus S, Arnesen H, Moum T, Abdelnoor M et al Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: Results from the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) randomized controlled trial. Am Heart J 2007; 154: 710.e1-710.e8.
21. Solheim S, Seljeflot I, Lunde K, Aukrust P, Yndestad A, Grøgaard HK et al. Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction. Am Heart J 2008; 155: 55.e1-55.e9.